US2012135499A1PendingUtilityA1
Exo-endo cellulase fusion protein
Est. expiryMar 25, 2024(expired)· nominal 20-yr term from priority
C07K 2319/00C12P 21/02C12P 21/06C07K 2319/50C12N 9/2437C12Y 302/01091C12N 15/625C12Y 302/01004C12N 15/80
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a heterologous exo-endo cellulase fusion construct, which encodes a fusion protein having cellulolytic activity comprising a catalytic domain derived from a fungal exo-cellobiohydrolase and a catalytic domain derived from an endoglucanase. The invention also relates to vectors and fungal host cells comprising the heterologous exo-endo cellulase fusion construct as well as methods for producing a cellulase fusion protein and enzymatic cellulase compositions.
Claims
exact text as granted — not AI-modified1 . A heterologous exo-endo cellulase fusion construct comprising in operable linkage from the 5′ end of said molecule
a. a DNA molecule encoding a signal sequence;
b. a DNA molecule encoding a catalytic domain of an exo-cellobiohydrolase; and
c. a DNA molecule encoding an endoglucanase catalytic domain.
2 . The heterologous exo-endo cellulase fusion construct according to claim 1 further comprising a linker sequence located 3′ of the catalytic domain of the exo-cellobiohydrolase and 5′ of the catalytic domain of the endoglucanase.
3 . The heterologous exo-endo cellulase fusion construct according to claim 1 further comprising a kexin site located after the linker sequence and before the coding region of the endoglucanase catalytic domain.
4 . The heterologous exo-endo fusion construct according to claim 1 further comprising a promoter of a filamentous fungus secretable protein, said promoter located in operable linkage 5′ of the coding region of the exo-cellobiohydrolase catalytic domain.
5 . The heterologous exo-endo fusion construct according to claim 4 wherein the promoter is a cbh promoter.
6 . The heterologous exo-endo fusion construct according to claim 5 wherein the promoter is a cbh1 promoter derived from T. reesei.
7 . The heterologous exo-endo fusion construct according to claim 1 wherein the exo-cellobiohydrolase is a CBH1.
8 . The heterologous exo-endo fusion construct according to claim 7 wherein said CBH1 comprises an amino acid sequence of at least 90% sequence identity with the sequence set forth in SEQ ID NO.: 6.
9 . The heterologous exo-endo fusion construct according to claim 1 wherein the endoglucanase catalytic domain is derived from a bacterial endoglucanase.
10 . The heterologous exo-endo fusion construct according to claim 9 wherein the bacterial endoglucanase catalytic domain is selected from the group consisting of an Acidothermus cellulolyticus GH5A endoglucanase I (E1) catalytic domain; an Acidothermus cellulolyticus GH74 endoglucanase (GH74-EG) catalytic domain: and a Thermobifida fusca E5 endoglucanase (Tf-E5) catalytic domain.
11 . The heterologous exo-endo fusion construct according to claim 10 wherein the endoglucanase is an Acidothermus cellulolyticus GH5A E1 catalytic domain.
12 . The heterologous exo-endo fusion construct according to claim 10 wherein the Acidothermus cellulolyticus GH5A E1 catalytic domain having an amino acid sequence of at least 90% sequence identity with the sequence set forth in SEQ ID NO. 8.
13 . The heterologous exo-endo fusion construct according to claim 1 further comprising a terminator sequence located 3′ to the endoglucanase catalytic domain.
14 . The heterologous exo-endo fusion construct according to claim 1 further comprising a selectable marker.
15 . A vector comprising in operable linkage a promoter of a filamentous fungus secretable protein, a DNA molecule encoding a signal sequence, a DNA molecule encoding a catalytic domain of a fungal exo-cellobiohydrolase, a DNA molecule encoding a catalytic domain of an endoglucanase, and a terminator.
16 . The vector according to claim 15 further comprising a selectable marker.
17 . The vector according to claim 15 further comprising a linker located 3′ of the exo-cellobiohydrolase (CBH) catalytic domain and 5′ of the EG catalytic domain.
18 . The vector according to claim 15 further comprising a kexin site.
19 . The vector according to claim 15 wherein the catalytic domain of the endoglucanase is derived from a bacterial endoglucanase.
20 . A fungal host cell transformed with a heterologous exo-endo cellulase fusion construct according to claim 1 .
21 . A fungal host cell transformed with a vector according to claim 15 .
22 . A recombinant fungal cell comprising the heterologous exo-endo cellulase fusion construct according to claim 1 .
23 . A recombinant fungal cell comprising a vector according to claim 15 .
24 . The recombinant fungal cell according to claim 22 wherein the fungal host cell is a Trichoderma host cell.
25 . The recombinant fungal cell according to claim 22 wherein the fungal host cell is a strain of T. reesei.
26 . The recombinant fungal cell according to claim 22 wherein at least one gene selected from the group consisting of the cbh1, cbh2, egl1 and eg/2 has been deleted from the fungal cells.
27 . An isolated cellulase fusion protein having cellulolytic activity which comprises an exo-cellobiohydrolase catalytic domain and an endoglucanase catalytic domain.
28 . The isolated cellulase fusion protein according to claim 27 wherein the exo-cellobiohydrolase is a CBH1.
29 . The isolated cellulase fusion protein according to claim 27 wherein the catalytic domain of the endoglucanase is derived from a bacterial cell.
30 . The isolated cellulase fusion protein according to claim 29 wherein bacterial cell is a strain of Acidothermus cellulolyticus.
31 . A cellulolytic composition comprising the isolated cellulase fusion protein according to claim 29 .
32 . A method of producing an enzyme having cellulolytic activity comprising, a) stably transforming a filamentous fungal host cell with a heterologous exo-endo cellulase fusion construct according to claim 1 ; b) cultivating the transformed fungal host cell under conditions suitable for said fungal host cell to produce an enzyme having cellulolytic activity; and c) recovering said enzyme.
33 . The method according to claim 32 wherein the filamentous fungal host cell is a Trichoderma cell.
34 . The method according to claim 32 wherein the filamentous fungal host cell is a T. reesei host cell.
35 . The method according to claim 32 wherein the exo-cellobiohydrolase is a CBH1 and the endoglucanase is selected from the group consisting of an Acidothermus cellulolyticus endoglucanase and a Thermobifida fusca endoglucanase.
36 . The method according to claim 32 wherein the recovered enzyme is selected from the group consisting of a cellulase fusion protein, components of the cellulase fusion protein, and a combination of the cellulase fusion protein and the components thereof.
37 . The method according to claim 32 wherein the recovered enzyme(s) is purified.
38 . A Trichoderma host cell which expresses a cellulase fusion protein, wherein said fusion protein comprises a catalytic domain of an exo-cellobiohydrolase and a catalytic domain of an endoglucanase.
39 . The Trichoderma host cell according to claim 38 wherein the host cell is a T. reesei cell.
40 . The Trichoderma host cell according to claim 38 wherein the exo-cellobiohydrolase is a CBH1 and the endoglucanase is an Acidothermus cellulolyticus endoglucanase.
41 . The Trichoderma host cell according to claim 38 wherein the endoglucanase is either an Acidothermus cellulolyticus E1 or GH74 endoglucanase.
42 . The Trichoderma host cell according to claim 38 wherein at least one gene selected from the group consisting of the cbh1, cbh2, egl1 and egl2 has been deleted from the host cell.
43 . A fungal cellulase composition comprising a cellulase fusion protein or components thereof, wherein the fusion protein or components thereof is the product of a recombinant Trichoderma spp. according to claim 38 .
44 . A fungal cellulase composition according to claim 43 wherein the cellulase fusion protein is a CBH1- Acidothermus cellulolyticus E1 fusion protein and the components are the cleaved products, CBH1 and Acidothermus E1.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.